![]() ![]() Palinski W, Yla-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL: Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Shoenfeld Y, Sherer Y, George J, Harats D: Autoantibodies associated with atherosclerosis. Zhou X, Hansson GK: Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Stemme S, Faber B, Holm J, Wiklund O, Witztum JL, Hansson GK: T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Ross R: The patogenesis of atherosclerosis: A perspective for the 1990s. Jonasson L, Holm J, Skalli O, Bondjers G, and Hansson GK: Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. J Intern Med 247:349-358, 2000įolcik VA, Aamir R, Cathcart MK: Cytokine modulation of LDL oxidation by activated human monocytes. Libby P: Changing concepts of atherogenesis. Free Radic Biol Med 13:341-390, 1992įrostegard J, Haegerstrand A, Gidlund M, Nilsson J: Biologically modified LDL increases the adhesive properties of endothelial cells. N Engl J Med 320:915-924, 1989Įsterbauer H, Gebicki J, Puhl H, Jurgens G: The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Modifications of low-density lipoprotein that increase its atherogenicity. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol. Ross R: Atherosclerosis-An inflammatory disease. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.Ross R, Glomset JA: The pathogenesis of atherosclerosis. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Next Generation Antibody Therapeutics Market Some other Trending Reports – Peripheral IV Catheter Market Key Segments Covered in Antibody Library Technology Industry Research It is essential for stakeholders in the biotechnology and pharmaceutical industries to collaborate, invest in research and development, and drive innovation to unlock the full potential of antibody library technologies in improving patient care. The market’s expansion potential is driven by the increasing demand for targeted therapies and the continuous advancements in display technologies and sequencing techniques. In conclusion, the antibody library technology market empowers drug discovery by providing researchers with advanced tools for antibody generation and optimization. Collaboration between academic institutions, biotechnology companies, and pharmaceutical organizations is crucial to harness these advancements and translate them into impactful therapies.įor In-Depth Competitive Analysis, Buy Now Ongoing research and development efforts focus on enhancing the diversity and functionality of antibody libraries, developing innovative selection strategies, and integrating automation and artificial intelligence into the discovery process. Looking ahead, the future of the antibody library technology market holds immense potential. The market expansion is further fueled by the advancements in next-generation sequencing and bioinformatics, allowing for deeper insights into antibody repertoire and accelerating the discovery process. Additionally, the expanding scope of therapeutic areas, including oncology, autoimmune diseases, and infectious diseases, provides ample opportunities for antibody discovery. The increasing demand for targeted therapies and personalized medicine fuels the need for novel antibody-based therapeutics. The growth potential of the antibody library technology market is driven by several factors. These technologies enhance the efficiency of antibody development, streamlining the drug discovery process. With the advancements in phage display, yeast display, and other display technologies, the market provides innovative platforms for antibody discovery and optimization. Antibody library technologies offer a systematic approach to generate large libraries of antibodies, enabling researchers to identify high-affinity and specific antibodies against targets of interest. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |